Corrales, NM – October 24, 2017 – Indica Labs, the leading provider of software for quantitative evaluation of digital pathology images, is pleased to announce
Corrales, NM – October 5, 2017 – Indica Labs Inc headquartered in Corrales, New Mexico, is pleased to announce the selection of the newly developed
Portland, OR – September 29, 2017 – MolecularMD, a provider of molecular and tissuebased clinical trial assays and diagnostics for oncology based drug development programs,
Dr. Keith J. Kaplan | July 31, 2017 | Source: Indica Labs Indica Labs announced today that Douglas Bowman has been appointed Vice President, Pharma
Indica Labs Appoints a Vice President, Pharma Services Read More »
Corrales, NM – April 24th 2017 – Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.
HALO® Deep Learning Technology Awarded for Automated Breast Cancer Metastasis Staging Read More »
Tokyo, 9 January, 2017 – Indica Labs expanded its international presence again this month with the establishment of a new office in Tokyo, Japan and
Discoveries from the field: Expediting drug developments and clinical trials with digital pathology and HALO image analysis Alex Klimowicz, PhD, Principal Scientist, Boehringer Ingelheim Pharmaceuticals
Indica Labs, Inc. and Advanced Cell Diagnostics (ACD) announce the signing of a co-marketing partnership agreement to advance quantitative analysis in ACD’s RNAscope Pharma Assay Services.
Philips and Indica Labs Team to Accelerate Cancer Research through Advanced Image Analysis
HALO® used as quantitative analysis platform in ground breaking melanoma drug study published in Nature
